EU allows use of UCB’s anti-epileptic Vimpat in children
The European Commission has ruled that UCB’s anti-epileptic Vimpat can be used in children.
Read on PharmaTimes
NICE nod for new Eylea indication
The National Institute for Health and Care Excellence (NICE) has issued a final positive recommendation for Bayer’s Eylea as a treatment for adults for the treatment of visual impairment due to myopic chorodial neovascularisation.
Read on PharmaTimes
Sanofi’s Kevzara will be funded for NHS use
Some patients with rheumatoid arthritis living in England and Wales should get ‘routine’ NHS access to Sanofi’s Kevzara after cost regulators issued draft guidelines deeming the drug cost effective.
Read on PharmaTimes
FDA warning on Intercept’s Ocaliva after patient deaths
US regulators have issued a safety communication warning of the risk for serious liver injury and death from incorrect dosing of Intercept Pharmaceuticals' Ocaliva in patients with primary biliary cholangitis.
Read on PharmaTimes
Join us at the London Marriott Hotel, Grosvenor Square for the event of the year!
The Awards Ceremony for Marketer & Communications Team of the Year will take place at the London Marriott Hotel, Grosvenor Square on Thursday 9 November.
Read on PharmaTimes
1
2
3
Next
